Skip to content
10-K

Annual Report

Telesis Bio Inc.

0000950170-24-038389

← back to feed
Filed
Mar 29, 2024 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 28, 2024 30.1M sh
Shares Diluted FY 2023 · Dec 31, 2023 29.85M sh
Shares Diluted FY 2023 · Dec 31, 2022 29.46M sh
Capex FY 2023 · Dec 31, 2023 $1.98M
Capex FY 2023 · Dec 31, 2022 $4.47M
Operating Cash Flow FY 2023 · Dec 31, 2023 −$34.67M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$38.72M
Long Term Debt FY 2023 · Dec 31, 2023 $5.27M
Long Term Debt FY 2023 · Dec 31, 2022 $19.65M
Cash And Equivalents FY 2023 · Dec 31, 2023 $1.57M
Cash And Equivalents FY 2023 · Dec 31, 2022 $30.42M
Stockholders Equity FY 2023 · Dec 31, 2023 $238K
Stockholders Equity FY 2023 · Dec 31, 2022 $46.57M
Stockholders Equity FY 2023 · Dec 31, 2021 $90.78M
Current Liabilities FY 2023 · Dec 31, 2023 $8.18M
Current Liabilities FY 2023 · Dec 31, 2022 $13.5M
Total Liabilities FY 2023 · Dec 31, 2023 $40.87M
Total Liabilities FY 2023 · Dec 31, 2022 $34.8M
Current Assets FY 2023 · Dec 31, 2023 $30.35M
Current Assets FY 2023 · Dec 31, 2022 $55.09M
Total Assets FY 2023 · Dec 31, 2023 $70.41M
Total Assets FY 2023 · Dec 31, 2022 $81.36M
Eps Diluted FY 2023 · Dec 31, 2023 −$1.64
Eps Diluted FY 2023 · Dec 31, 2022 −$1.65
Eps Basic FY 2023 · Dec 31, 2023 −$1.64
Eps Basic FY 2023 · Dec 31, 2022 −$1.65
Sga Expense FY 2023 · Dec 31, 2023 $21.09M
Sga Expense FY 2023 · Dec 31, 2022 $22.13M
Rd Expense FY 2023 · Dec 31, 2023 $17.5M
Rd Expense FY 2023 · Dec 31, 2022 $23.46M
Net Income FY 2023 · Dec 31, 2023 −$47.72M
Net Income FY 2023 · Dec 31, 2022 −$48.47M
Operating Income FY 2023 · Dec 31, 2023 −$46.54M
Operating Income FY 2023 · Dec 31, 2022 −$46.49M
Gross Profit FY 2023 · Dec 31, 2023 $16.95M
Gross Profit FY 2023 · Dec 31, 2022 $15.6M
Cost Of Revenue FY 2023 · Dec 31, 2023 $10.56M
Cost Of Revenue FY 2023 · Dec 31, 2022 $11.84M
Revenue FY 2023 · Dec 31, 2023 $27.51M
Revenue FY 2023 · Dec 31, 2022 $27.44M